Role of AMP-activated protein kinase in regulating hypoxic survival and proliferation of mesenchymal stem cells

Cardiovascular Research

Volumn 101, Issue 1, 2014, Pages 20-29

  De Meester, Carole ^a   Timmermans, Aurélie D ^a   Balteau, Magali ^a   Ginion, Audrey ^a   Roelants, Véronique ^a   Noppe, Gauthier ^a   Porporato, Paolo E ^a   Sonveaux, Pierre ^a   Viollet, Benoît ^b,c,d   Sakamoto, Kei ^e   Feron, Olivier ^a   Horman, Sandrine ^a   Vanoverschelde, Jean Louis ^a,f   Beauloye, Christophe ^a,f   Bertrand, Luc ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b INSTITUT COCHIN   (France)

^c CNRS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e EPFL   (Switzerland)

^f CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

AMPK; Glycolysis; Hypoxia; Mesenchymal stem cells; Proliferation

Indexed keywords

6,7 DIHYDRO 4 HYDROXY 3 (2' HYDROXY 1,1' BIPHENYL 4 YL) 6 OXOTHIENO[2,3 B]PYRIDINE 5 CARBONITRILE; ELONGATION FACTOR 2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; OXYGEN; PROTEIN P21; PROTEIN P27; S6 KINASE;

ADULT; ANIMAL CELL; ARTICLE; BONE MARROW; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVE SITE; HEART MUSCLE CELL; HYPOXIA; LONG TERM EXPOSURE; MESENCHYMAL STEM CELL; METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REGULATORY MECHANISM;

AMPK; GLYCOLYSIS; HYPOXIA; MESENCHYMAL STEM CELLS; PROLIFERATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANOXIA; CELL PROLIFERATION; CELL SURVIVAL; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ELONGATION FACTOR 2 KINASE; ENZYME ACTIVATION; HEART DISEASES; ISOENZYMES; MESENCHYMAL STROMAL CELLS; MICE; MITOCHONDRIAL TURNOVER; MYOCYTES, CARDIAC; P21-ACTIVATED KINASES; PYRONES; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; THIOPHENES;

EID: 84891352333     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt227     Document Type: Article

References (41)

1. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007;167:989-997.
2. Behfar A, Yamada S, Crespo-Diaz R, Nesbitt JJ, Rowe LA, Perez-Terzic C et al. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol 2010;56:721-734.
3. Rosova I, Dao M, Capoccia B, Link D, Nolta JA. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 2008;26:2173-2182.
4. HardieDG, Sakamoto K. AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiology 2006;21:48-60.
5. Viollet B, Athea Y, Mounier R, Guigas B, Zarrinpashneh E, Horman S et al.AMPK: lessons from transgenic and knockout animals. Front Biosci 2009;14:19-44.
6. Horman S, Beauloye C, Vanoverschelde JL, Bertrand L. AMP-activated protein kinase in the control of cardiac metabolism and remodeling. Curr Heart Fail Rep 2012;9:164-173.
7. Beauloye C, Bertrand L, Horman S, Hue L. AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure. Cardiovasc Res 2011;90: 224-233.
8. Sakamoto K, Zarrinpashneh E, Budas GR, Pouleur AC, Dutta A, Prescott AR et al. Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1. Am J Physiol Endocrinol Metab 2006;290:E780-E788.
9. Zarrinpashneh E, Carjaval K, Beauloye C, Ginion A, Mateo P, PouleurACet al. Role of the alpha2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia. Am J Physiol Heart Circ Physiol 2006;291:H2875-H2883.
10. Russell RR III, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M et al. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 2004;114:495-503.
11. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 2005;280:29060-29066.
12. Miranda L, Carpentier S, Platek A, Hussain N, Gueuning MA, Vertommen D et al. AMP-activated protein kinase induces actin cytoskeleton reorganization in epithelial cells. Biochem Biophys Res Commun 2010;396:656-661.
13. Horman S, Morel N, Vertommen D, Hussain N, Neumann D, Beauloye C et al. AMP-activated protein kinase phosphorylates and desensitizes smooth muscle myosin light chain kinase. J Biol Chem 2008;283:18505-18512.
14. Canto C, Auwerx J. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol 2009;20:98-105.
15. Chen CT, Hsu SH, Wei YH. Upregulation of mitochondrial function and antioxidant defense in the differentiation of stem cells. Biochim Biophys Acta 2010;1800:257-263.
16. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 2005;18:283-293.
17. Rattan R, Giri S, Singh AK, Singh I. 5-Aminoimidazole-4-carboxamide-1- beta-d-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase. J Biol Chem 2005;280:39582-39593.
18. Skapek SX, Rhee J, Spicer DB, Lassar AB. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 1995;267:1022-1024.
19. Quaroni A, Tian JQ, Seth P, Ap Rhys C. P27(Kip1) is an inducer of intestinal epithelial cell differentiation. Am J Physiol Cell Physiol 2000;279:C1045-C1057.
20. Xia K, Xue H, Dong D, Zhu S,Wang J, Zhang Q et al. Identification of the proliferation/differentiation switch in the cellular network of multicellular organisms. PLoS Comput Biol 2006;2:e145.
21. Bertrand L, Ginion A, Beauloye C, Hebert AD, Guigas B, Hue L et al. AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. Am J Physiol Heart Circ Physiol 2006;291: H239-H250.
22. Roelants V, Labar D, de Meester C, Havaux X, Tabilio A, Gambhir SS et al. Comparison between adenoviral and retroviral vectors for the transduction of the thymidine kinase PET reporter gene in rat mesenchymal stem cells. J Nucl Med 2008;49:1836-1844.
23. Balteau M, Tajeddine N, de Meester C, Ginion A, Des Rosiers C, BradyNRet al.NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1. Cardiovasc Res 2011;92:237-246.
24. Goransson O, McBride A, Hawley SA, Ross FA, Shpiro N, Foretz M et al. Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. J Biol Chem 2007;282:32549-32560.
25. Cool B, Zinker B, ChiouW, Kifle L, Cao N, PerhamMet al. Identification and characterization of a small moleculeAMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab 2006;3:403-416.
26. Scott JW, van Denderen BJ, Jorgensen SB, Honeyman JE, Steinberg GR, Oakhill JS et al. Thienopyridone drugs are selective activators of AMP-activated protein kinase beta1-containing complexes. Chem Biol 2008;15:1220-1230.
27. Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, Vincent MF et al. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol 2000;10:1247-1255.
28. Semenza GL. HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev 2010;20:51-56.
29. Stahmann N,Woods A, Carling D, Heller R. Thrombin activates AMP-activated protein kinase in endothelial cells via a pathway involving Ca2+/calmodulin-dependent protein kinase kinase beta. Mol Cell Biol 2006;26:5933-5945.
30. Chung S, Dzeja PP, Faustino RS, Perez-Terzic C, Behfar A, Terzic A. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat Clin Pract Cardiovasc Med 2007;4(Suppl 1):S60-S67.
31. Deschepper M, Oudina K, David B, Myrtil V, Collet C, Bensidhoum M et al. Survival and function of mesenchymal stem cells (MSCs) depend on glucose to overcome exposure to long-term, severe and continuous hypoxia. J Cell Mol Med 2011;15:1505-1514.
32. Candelario KM, Shuttleworth CW, Cunningham LA. Neural stem/progenitor cells display a low requirement for oxidative metabolism independent of hypoxia inducible factor-1alpha expression. J Neurochem 2013;125:420-429.
33. Folmes CD, Nelson TJ, Martinez-Fernandez A, Arrell DK, Lindor JZ, Dzeja PP et al. Somatic oxidative bioenergetics transitions into pluripotency- dependent glycolysis to facilitate nuclear reprogramming. Cell Metab 2011;14:264-271.
34. Varum S, Rodrigues AS, Moura MB, Momcilovic O, Easley CA, Ramalho-Santos J et al. Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS ONE 2011;6:e20914.
35. Vander Heiden MG, Cantley LC, Thompson CB. Understanding theWarburg effect: the metabolic requirements of cell proliferation. Science 2009;324:1029-1033.
36. Zang Y, Yu LF, Nan FJ, Feng LY, Li J. AMP-activated protein kinase is involved in neural stem cell growth suppression and cell cycle arrest by 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside and glucose deprivation by down-regulating phospho-retinoblastoma protein and cyclin D. J Biol Chem 2009;284:6175-6184.
37. Green AS, Chapuis N, Maciel TT, Willems L, Lambert M, Arnoult C et al. The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation. Blood 2010;116:4262-4273.
38. Short JD, Dere R, Houston KD, Cai SL, Kim J, Bergeron JM et al. AMPK-mediated phosphorylation of murine p27 at T197 promotes binding of 14-3-3 proteins and increases p27 stability. Mol Carcinog 2010;49:429-439.
39. Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 2007;9:218-224.
40. Neufeld TP. Autophagy and cell growth-the yin and yang of nutrient responses. J Cell Sci 2012;125:2359-2368.
41. Zhu Z, Fu C, Li X, Song Y, Li C, Zou M et al. Prostaglandin E2 promotes endothelial differentiation from bone marrow-derived cells throughAMPK activation. PLoS ONE 2011; 6:e23554.